Correlation Between Lyxor 1 and ASTELLAS PHARMA
Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyxor 1 and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Lyxor 1 and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and ASTELLAS PHARMA.
Diversification Opportunities for Lyxor 1 and ASTELLAS PHARMA
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyxor and ASTELLAS is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and ASTELLAS PHARMA go up and down completely randomly.
Pair Corralation between Lyxor 1 and ASTELLAS PHARMA
Assuming the 90 days trading horizon Lyxor 1 is expected to generate 0.43 times more return on investment than ASTELLAS PHARMA. However, Lyxor 1 is 2.34 times less risky than ASTELLAS PHARMA. It trades about 0.02 of its potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.01 per unit of risk. If you would invest 2,362 in Lyxor 1 on August 25, 2024 and sell it today you would earn a total of 67.00 from holding Lyxor 1 or generate 2.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyxor 1 vs. ASTELLAS PHARMA UNSPADR
Performance |
| Timeline |
| Lyxor 1 |
| ASTELLAS PHARMA UNSPADR |
Lyxor 1 and ASTELLAS PHARMA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyxor 1 and ASTELLAS PHARMA
The main advantage of trading using opposite Lyxor 1 and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.| Lyxor 1 vs. Lyxor Fed Funds | Lyxor 1 vs. Lyxor BofAML USD | Lyxor 1 vs. Lyxor Index Fund | Lyxor 1 vs. Lyxor 1 TecDAX |
| ASTELLAS PHARMA vs. Johnson Johnson | ASTELLAS PHARMA vs. Merck Co | ASTELLAS PHARMA vs. Roche Holding Ltd | ASTELLAS PHARMA vs. Amgen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |